37.78

37.78 (-0.05%)

As of Mar 06, 2024

Arcturus Therapeutics Holdings Inc. [ARCT]

Source: 

Company Overview

Arcturus is a late-stage global clinical messenger RNA medicines company focused on the development of infectious disease vaccines and significant opportunities within liver and respiratory rare diseases. In addition to our messenger RNA platform, our proprietary lipid nanoparticle delivery system, LUNAR  , has the potential to enable multiple nucleic acid medicines, and our proprietary self-amplifying mRNA technology (Self-Transcribing and Replicating RNA, or STARR™, technology) has the potential to provide longer-lasting RNA and sustained protein expression.

CountryUS
Headquarterssan diegocalifornia
Phone Number(858) 900-2660
Industrypharmaceutical preparations
CEOJoseph E. Payne
Websitewww.arcturusrx.com